Search

Cost conundrum: the investment in clinical trials remains the same but approved drugs will have a smaller market. So how is Personalised Medicine to be financed?

A new ‘vision’ from Brussels offers something for everyone – including research and innovation. But in the end, it comes off as empty rhetoric.

The first €1M grants from the EIT will be signed next week. Now the real work begins, chairman Martin Schuurmans tells Science|Business.

After 7 years of deliberation, the European Commission is to authorise the Amflora genetically modified potato to be cultivated for industrial purposes.

A new study shows that the costs associated with a single new crop pest or disease agent have increased by 68.4 per cent in the past decade.

The League of European Research Universities (LERU) has released a paper setting out its vision for doctoral education beyond 2010.

Europe is always an also-ran in ICT: New Commissioner Neelie Kroes tells Science|Business how she plans to reverse two decades of failure.

Imperial College London is to make its expertise in innovation management, technology transfer and engineering available to the Innovation Outreach Programme.

The old established centres are being challenged by the emergence of new poles of world science and innovation. But could this benefit Europe, the US and Japan?